Drug intelligence / Profile preview

AGuIX + Rose Bengal

Development stage
Preclinical
Lead developer
NH TherAguix
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Intraperitoneal
01

Overview

AGuIX + Rose Bengal is an investigational combination therapy that merges the properties of AGuIX nanoparticles and the photosensitizer Rose Bengal for enhanced cancer treatment. AGuIX are ultrasmall gadolinium-based nanoparticles designed as theranostic agents, providing both MRI contrast enhancement and radiosensitization to improve the efficacy of radiotherapy by selectively accumulating in tumors and amplifying radiation-induced damage[6][1]. Rose Bengal is a xanthene dye with established use as a diagnostic agent, but it also acts as a photosensitizer in photodynamic therapy (PDT), generating reactive oxygen species upon light activation to induce cytotoxicity in tumor cells[4][5]. The combination aims to leverage the tumor-targeting, imaging, and radiosensitizing capabilities of AGuIX with the photodynamic effects of Rose Bengal for synergistic anti-cancer activity. This approach is under preclinical investigation for various solid tumors.

02

Targets

NRP1 (Neuropilin-1)

Beyond the preview

Go deeper on AGuIX + Rose Bengal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGuIX + Rose Bengal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call